VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
1 Month to 10 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Premature newborns with less than 32 weeks of gestation.
Low birth weight (less than 1500gr)
Stage V ROP.
The parents has signed the informed consent.
Previous treatment of ROP.
Surgery or another ocular pathology of any type.
Systemic diseases, including diabetes mellitus, congestive heart failure acute renal insufficiency, Chronic renal insufficiency, high blood pressure.